138 related articles for article (PubMed ID: 33740044)
1. Factors Associated With Being Overweight and Obesity in People Living With Human Immunodeficiency Virus on Antiretroviral Therapy: Socioclinical, Inflammation, and Metabolic Markers.
Goupil de Bouillé J; Vigouroux C; Plessis L; Ghislain M; Teglas JP; Boufassa F; Goujard C; Vignes D; Bouchaud O; Salmon D; Meyer L; Abgrall S;
J Infect Dis; 2021 Nov; 224(9):1570-1580. PubMed ID: 33740044
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults.
Mave V; Erlandson KM; Gupte N; Balagopal A; Asmuth DM; Campbell TB; Smeaton L; Kumarasamy N; Hakim J; Santos B; Riviere C; Hosseinipour MC; Sugandhavesa P; Infante R; Pillay S; Cardoso SW; Tripathy S; Mwelase N; Berendes S; Andrade BB; Thomas DL; Bollinger RC; Gupta A;
J Infect Dis; 2016 Jul; 214(1):65-72. PubMed ID: 26962236
[TBL] [Abstract][Full Text] [Related]
3. Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons.
Lakey W; Yang LY; Yancy W; Chow SC; Hicks C
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):435-40. PubMed ID: 23072344
[TBL] [Abstract][Full Text] [Related]
4. Does region of origin influence the timing and outcome of first-line antiretroviral therapy in France?
Gatey C; Brun A; Hamet G; Diamantis S; Sellier P; Bouchaud O; Garrait V; Rozenbaum W; Molina JM; Abgrall S;
HIV Med; 2019 Feb; 20(2):175-181. PubMed ID: 30506853
[TBL] [Abstract][Full Text] [Related]
5. Association between obesity and combination antiretroviral therapy (cART) adherence among persons with early-stage HIV infection initiating cART.
Musinguzi N; Stanford FC; Boatin AA; Orrell C; Asiimwe S; Siedner M; Haberer JE;
Int J Obes (Lond); 2021 Aug; 45(8):1855-1859. PubMed ID: 34007011
[TBL] [Abstract][Full Text] [Related]
6. Circulating interleukin-6, soluble CD14, and other inflammation biomarker levels differ between obese and nonobese HIV-infected adults on antiretroviral therapy.
Koethe JR; Dee K; Bian A; Shintani A; Turner M; Bebawy S; Sterling TR; Hulgan T
AIDS Res Hum Retroviruses; 2013 Jul; 29(7):1019-25. PubMed ID: 23469772
[TBL] [Abstract][Full Text] [Related]
7. [Serum leptin and adiponectin concentrations in patients infected with human immunodeficiency virus type 1 (HIV-1) on antiretroviral therapy].
Leszczyszyn-Pynka M; Pynka S; Boroń-Kaczmarska A; Pilarska K
Endokrynol Pol; 2005; 56(1):19-24. PubMed ID: 16335669
[TBL] [Abstract][Full Text] [Related]
8. Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France.
de Monteynard LA; Dray-Spira R; de Truchis P; Grabar S; Launay O; Meynard JL; Khuong-Josses MA; Gilquin J; Rey D; Simon A; Pavie J; Mahamat A; Matheron S; Costagliola D; Abgrall S;
PLoS One; 2015; 10(3):e0118492. PubMed ID: 25734445
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial.
Guehi C; Badjé A; Gabillard D; Ouattara E; Koulé SO; Moh R; Ekouevi D; Ahibo H; N'Takpé JB; Menan GK; Deschamps N; Lecarrou J; Eholié S; Anglaret X; Danel C
AIDS Res Ther; 2016; 13():12. PubMed ID: 26925155
[TBL] [Abstract][Full Text] [Related]
10. Obesity is associated with greater inflammation and monocyte activation among HIV-infected adults receiving antiretroviral therapy.
Conley LJ; Bush TJ; Rupert AW; Sereti I; Patel P; Brooks JT; Baker JV;
AIDS; 2015 Oct; 29(16):2201-7. PubMed ID: 26544583
[TBL] [Abstract][Full Text] [Related]
11. Sub-Saharan African migrants have slower initial CD4+ cell recovery after combined antiretroviral treatment initiation than French natives.
Seng R; Ghislain M; Girard PM; Cotte L; Meybeck A; Raffi F; Abgrall S; Yazdanpanah Y; Goujard C; Dray-Spira R; Meyer L
AIDS; 2017 Jun; 31(9):1323-1332. PubMed ID: 28492394
[TBL] [Abstract][Full Text] [Related]
12. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
13. Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy.
Hattab S; Guiguet M; Carcelain G; Fourati S; Guihot A; Autran B; Caby F; Marcelin AG; Costagliola D; Katlama C
HIV Med; 2015 Oct; 16(9):553-62. PubMed ID: 25944318
[TBL] [Abstract][Full Text] [Related]
14. Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression.
Castillo-Mancilla JR; Brown TT; Erlandson KM; Palella FJ; Gardner EM; Macatangay BJ; Breen EC; Jacobson LP; Anderson PL; Wada NI
Clin Infect Dis; 2016 Dec; 63(12):1661-1667. PubMed ID: 27660234
[TBL] [Abstract][Full Text] [Related]
15. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord
HIV Med; 2018 Jan; 19(1):42-48. PubMed ID: 28741837
[TBL] [Abstract][Full Text] [Related]
16. Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients.
Tedaldi EM; Brooks JT; Weidle PJ; Richardson JT; Baker RK; Buchacz K; Moorman AC; Wood KC; Holmberg SD;
J Acquir Immune Defic Syndr; 2006 Sep; 43(1):35-41. PubMed ID: 16885779
[TBL] [Abstract][Full Text] [Related]
17. Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy.
Vigouroux C; Maachi M; Nguyên TH; Coussieu C; Gharakhanian S; Funahashi T; Matsuzawa Y; Shimomura I; Rozenbaum W; Capeau J; Bastard JP
AIDS; 2003 Jul; 17(10):1503-11. PubMed ID: 12824788
[TBL] [Abstract][Full Text] [Related]
18. Metabolic markers during pregnancy and their association with maternal and newborn weight status.
Perichart-Perera O; Muñoz-Manrique C; Reyes-López A; Tolentino-Dolores M; Espino Y Sosa S; Ramírez-González MC
PLoS One; 2017; 12(7):e0180874. PubMed ID: 28749954
[TBL] [Abstract][Full Text] [Related]
19. Association of Lower Adiponectin Plasma Levels, Increased Age and Smoking with Subclinical Atherosclerosis in Patients with HIV-1 Infection.
Bellinati PQ; Alfieri DF; Flauzino T; Junior PFG; Rossi DJ; Breganó JW; Simão ANC; de Almeida ERD; Lozovoy MAB; Reiche EMV
Curr HIV Res; 2020; 18(4):292-306. PubMed ID: 32516102
[TBL] [Abstract][Full Text] [Related]
20. Predictors of faster virological suppression in early treated infants with perinatal HIV from Europe and Thailand.
European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) and Early-treated Perinatally HIV-infected Individuals: Improving Childrenʼs Actual Life with Novel Immunotherapeutic Strategies (EPIICAL) study groups
AIDS; 2019 Jun; 33(7):1155-1165. PubMed ID: 30741823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
